BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29885197)

  • 41. The prevention of cervical cancer in Africa.
    Fiander AN
    Womens Health (Lond); 2011 Jan; 7(1):121-32. PubMed ID: 21175396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human papillomavirus (HPV) infection, cervical cancer and vaccination against HPV: a Nordic perspective.
    Kjaer SK
    Acta Obstet Gynecol Scand; 2007; 86(11):1286-9. PubMed ID: 17963055
    [No Abstract]   [Full Text] [Related]  

  • 43. Assessing the impact of new cervical cancer screening guidelines.
    Baker E
    MLO Med Lab Obs; 2013 Feb; 45(2):28-9. PubMed ID: 24133862
    [No Abstract]   [Full Text] [Related]  

  • 44. Changes on the horizon for cervical cancer screening.
    Isidean SD; Shinder GA
    Prev Med; 2017 May; 98():1-2. PubMed ID: 28034732
    [No Abstract]   [Full Text] [Related]  

  • 45. Racial/Ethnic Disparities in Cervical Cancer Screening and Outcomes.
    Musselwhite LW; Oliveira CM; Kwaramba T; de Paula Pantano N; Smith JS; Fregnani JH; Reis RM; Mauad E; Vazquez FL; Longatto-Filho A
    Acta Cytol; 2016; 60(6):518-526. PubMed ID: 27825171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Towards cervical cancer eradication: joint force of HPV vaccination and HPV-based cervical cancer screening.
    Poljak M
    Clin Microbiol Infect; 2015 Sep; 21(9):806-7. PubMed ID: 26068650
    [No Abstract]   [Full Text] [Related]  

  • 47. Diagnostic methods and techniques in cervical cancer prevention Part II: Molecular diagnostics of HPV infection.
    Vince A; Lepej SZ
    Med Glas (Zenica); 2010 Feb; 7(1):18-25. PubMed ID: 20387720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preventing cervical cancer.
    Cain JM; Howett MK
    Science; 2000 Jun; 288(5472):1753-5. PubMed ID: 10877694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening for cervical cancer: controversy and contention or thoughtful analysis.
    Frable WJ
    Cancer; 2007 Jun; 111(3):143-4. PubMed ID: 17487849
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cervical cancer--possibilities of detection of human papillomavirus].
    Ondryášová H; Koudeláková V; Hajdúch M
    Ceska Gynekol; 2013 Jun; 78(3):289-94. PubMed ID: 23869837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus vaccination and cervical cancer screening by socioeconomic status, Victoria.
    Barbaro B; Brotherton JM; Gertig DM
    Med J Aust; 2012 Apr; 196(7):445. PubMed ID: 22509873
    [No Abstract]   [Full Text] [Related]  

  • 53. [Safe implementation of HPV testing in the Norwegian Cervical Cancer Screening Programme].
    Tropé A; Engesæter B; Nygård M; Andreassen T; Lönnberg S; Ursin G
    Tidsskr Nor Laegeforen; 2017 Sep; 137(17):. PubMed ID: 28925234
    [No Abstract]   [Full Text] [Related]  

  • 54. Human papillomavirus and cervical disease in adolescents.
    Guido R
    Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of HPV DNA testing in modern gynaecological practice.
    Ronco G; Giorgi Rossi P
    Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():107-118. PubMed ID: 28918099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [HPV screening for cervical cancer--the calculation of the Swedish National Board of Health and Welfare is too pessimistic].
    Wilander E
    Lakartidningen; 2015 Dec; 112():. PubMed ID: 26625106
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cervical cancer screening: restoration or reconstruction?].
    Riethmuller D
    Gynecol Obstet Fertil; 2009; 37(7-8):671-9. PubMed ID: 19577501
    [No Abstract]   [Full Text] [Related]  

  • 58. Cervical cancer screening in Switzerland: time to rethink the guidelines.
    Vassilakos P; Catarino R; Frey Tirri B; Petignat P
    Swiss Med Wkly; 2015; 145():w14112. PubMed ID: 25664576
    [No Abstract]   [Full Text] [Related]  

  • 59. The "Jade Goody effect": what now for cervical cancer prevention?
    Bowring J; Walker P
    J Fam Plann Reprod Health Care; 2010 Apr; 36(2):51-4. PubMed ID: 20406542
    [No Abstract]   [Full Text] [Related]  

  • 60. [The impact of natural history and genital tract distribution of human papillomavirus on technology for cervical cancer screening].
    Wu ZN; Chen W
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):241-5. PubMed ID: 27087368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.